glp-1 receptor agonists Comparing Ozempic, Wegovy and Other Drugs New GLP-1 Guidelines for Type
Description
Chen BD, Zhao WC, Dong JD, Sima H
Patients taking tirzepatide 10 mg achieved an average of 19.5% weight loss, and patients taking tirzepatide 15 mg achieved an average of 20.9% weight loss
More Powerful Glycemic Control Both tirzepatide and retatrutide significantly improve blood sugar control
Lancet 2014
Bremholm L, Andersen UB, Hornum M, Hilsted L, Veedfald S, Hartmann B, et al
J Clin Endocrinol Metab (2022) 107:36378
